top of page

Australia's TGA: Guidance on Regulation of Software based Medical Devices

Writer's picture: Sharan MuruganSharan Murugan

Recently on 2nd June, 2023 Australia's Therapeutic Goods Administration (TGA) released guidance on the "Regulation of Software based Medical Devices".

"Software based medical devices are medical devices that incorporate software or are software".


These devices either include software or are entirely software-based, such as software as a medical device. They may also rely on specific hardware to fulfill their intended purpose.


Software (including mobile apps) is a medical device if it fits within the definition of a medical device in section 41BD of the Therapeutic Goods Act 1989- external site, unless otherwise excluded.


This guidance aims to assist manufacturers and sponsors in comprehending the TGA's interpretation of requirements and provides guidance on how they can ensure compliance with those requirements. This is a general guide, and it is the sole responsibility of each manufacturer or sponsor to thoroughly understand and adhere to these requirements.


The purpose of this guidance and its related guidances is to offer insights into the regulatory requirements in Australia for software and applications that meet the defined criteria of a medical device.


Click this LINK to know more about topics such as Software as a Medical Device (SaMD) – use of data collection components, Artificial Intelligence Chat, Text, and Language, etc.

Comentários


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page